Compounds > daunorubicin

Page last updated: 2024-08-23

daunorubicin and silicon

daunorubicin has been researched along with silicon in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andrew, JS; Cheng, L; Freeman, WR; Pearson, L; Sailor, MJ; Wu, EC	1
Andrew, JS; Buyanin, A; Kinsella, JM; Sailor, MJ; Wu, EC	1
Cheng, L; Chhablani, J; Freeman, WR; Hartmann, KI; Kim, JS; Nieto, A; Sailor, MJ; Wu, EC	1
Cheng, L; Freeman, WR; Hou, H; Ma, F; Nieto, A; Sailor, MJ	1
Cheng, L; Freeman, WR; Hou, H; Huffman, K; Rios, S; Sailor, MJ	1
Cheng, L; Freeman, WR; Huffman, K; Li, F; Sailor, M; Wang, Y; Warther, D; Xiao, Y	1

Other Studies

6 other study(ies) available for daunorubicin and silicon

Article	Year
Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials, 2011, Volume: 32, Issue:7 Topics: Cell Line; Daunorubicin; Drug Delivery Systems; Humans; Nanostructures; Silicon	2011
Suitability of porous silicon microparticles for the long-term delivery of redox-active therapeutics. Chemical communications (Cambridge, England), 2011, May-28, Volume: 47, Issue:20 Topics: Antibiotics, Antineoplastic; Cell Line; Daunorubicin; Drug Carriers; Humans; Microscopy, Fluorescence; Nanostructures; Oxidation-Reduction; Porosity; Silicon	2011
Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:5 Topics: Animals; Chromatography, Liquid; Daunorubicin; Drug Delivery Systems; Intravitreal Injections; Particle Size; Porosity; Rabbits; Silicon; Spectrometry, Mass, Electrospray Ionization; Time Factors; Topoisomerase II Inhibitors	2013
Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon. Journal of controlled release : official journal of the Controlled Release Society, 2014, Mar-28, Volume: 178 Topics: Animals; Antibiotics, Antineoplastic; Cell Line; Cell Proliferation; Daunorubicin; Delayed-Action Preparations; Drug Delivery Systems; Humans; Intravitreal Injections; Oxidation-Reduction; Porosity; Rabbits; Silicon; Vitreous Body	2014
A Novel Approach of Daunorubicin Application on Formation of Proliferative Retinopathy Using a Porous Silicon Controlled Delivery System: Pharmacodynamics. Investigative ophthalmology & visual science, 2015, Volume: 56, Issue:4 Topics: Animals; Daunorubicin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Porosity; Rabbits; Silicon; Topoisomerase II Inhibitors; Vitreoretinopathy, Proliferative; Vitreous Body	2015
Porous silicon based intravitreal platform for dual-drug loading and controlled release towards synergistic therapy. Drug delivery, 2018, Volume: 25, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Daunorubicin; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Drug Synergism; Female; Male; Microspheres; Particle Size; Porosity; Rabbits; Silicon; Spectroscopy, Fourier Transform Infrared; Vitreous Body	2018